The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
SCOT: Short Course Oncology Therapy—A comparison of 12 and 24 weeks of adjuvant chemotherapy in colorectal cancer.
J. Paul
No relevant relationships to disclose
A. Briggs
No relevant relationships to disclose
A. Harkin
No relevant relationships to disclose
A. M. Haydon
No relevant relationships to disclose
T. Iveson
Honoraria - Roche
Research Funding - Pfizer; Roche
M. Masterson
No relevant relationships to disclose
R. A. Midgley
No relevant relationships to disclose
J. Cassidy
No relevant relationships to disclose